Multi-source Data to Insights - How to navigate the new reality for Pharma
Over the last few years there has been huge growth in the availability of digital data sources and health data.
This rapid growth brings both opportunities for increased customer insight generation and greater confidence in these insights. Along with challenges of data overload, data integration and skill-gaps. The latest Ipsos Point of View 'Multi-source Data to Insights - How to navigate the new reality for Pharma' investigates these challenges pharma organisations and other industries face daily.
Ipsos believes in the value of multi-source data analysis to help our clients be competitive and deliver real value to their customers. This paper explores the latest thinking on the subject, learnings we have generated from working across industries, and conversations with our healthcare clients. Here we outline our view on the future of multi-source data within pharma, specifically in regard to challenges faced, barriers experienced, and how they can be addressed. Concluding with three key recommendations to enable better decision-making.
The benefits of multi-source date are substantial, providing more trust and confidence in data and satisfied stakeholders. Having the right building blocks to overcome these challenges can enable organisations to become data-driven, which is achievable in the short term with a limited budget and minimal barriers.
